Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03968328 · ClinicalTrials.gov registry record
Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 315
- Enrollment target
NCT03968328: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT03968328 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 315 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03968328 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 315 participants
- Enrollment target
Study Summary
This trial uses an interview and a survey to gather information from cancer patients about the onset of their fever and the administration of antibiotics. Collecting information from patients may help doctors to assess the relationship between time to antibiotic administration and inhospital cause specific death, intensive care unit admission, hospital length of stay, and positive blood cultures.
Primary Outcome
Will perform univariate logistic regression analysis to assess the effect of time to antibiotic administration on death 14 days post fever onset. Will build multivariate logistic regression model(s) to further assess the effect of time to antibiotic administration on death 14 days post fever onset adjusting for other potential confounders.
Interventions
- OTHER Survey Administration
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2015-06-19 |
| Est. Completion | 2023-01-17 |
What the finished NCT03968328 record still lists
NCT03968328 is an observational study that tracks outcomes without assigning an intervention. The registered 315 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Survey Administration is the first listed.
NCT03968328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03968328 about?
NCT03968328 is a clinical study titled "Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients". This trial uses an interview and a survey to gather information from cancer patients about the onset of their fever and the administration of antibiotics. Collecting information from patients may help doctors to assess the relationship between time to antibiotic administration and inhospital cause s...
What is the current status of trial NCT03968328?
This trial is currently completed. The enrollment target is 315 participants. The study started on 2015-06-19. Estimated completion is 2023-01-17.
What interventions are being tested in trial NCT03968328?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT03968328?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04812366 · 315 participants · Phase 2
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- NCT05101460 · 315 participants
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
- NCT05897320 · 315 participants · Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- NCT06439082 · 315 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI